RVLP

RVL Pharmaceuticals (RVLP)

RVL Pharmaceuticals PLC

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RVLP

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/01/18	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/12/21	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/11/27	20 : 50	GlobeNewswire Inc.	RVL Completes Financial Restructuring	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/11/16	23 : 11	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/11/02	05 : 27	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/24	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/24	02 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/21	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/21	04 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/21	02 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/19	05 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/14	06 : 28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/14	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/12	19 : 50	GlobeNewswire Inc.	RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/30	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/23	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/06	05 : 18	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/06	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/05	20 : 45	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/01	03 : 23	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/30	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/26	06 : 21	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/26	05 : 17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/24	06 : 30	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/24	05 : 05	GlobeNewswire Inc.	RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/19	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/18	06 : 06	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/18	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/18	05 : 05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/16	21 : 00	GlobeNewswire Inc.	RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	NASDAQ:RVLP	RVL Pharmaceuticals PLC